EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms

Chiara Mura, Silvia Corrias, Mara Lecca, Maria Letizia Lai, Gian Luigi Canu, Fabio Medas, Stefano Mariotti, Pietro Giorgio Calò, Paola Caria, Giulia Lanzolla iD, Francesco Boi

European Journal of Endocrinology · 06.04.2026 · 194 (4) · 510-518

DOI: 10.1093/ejendo/lvag059 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Endocrinology, online erschienen am 16.04.2026. Verfasst von Chiara Mura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari 09042, Italy. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Thyroid Neoplasms, Age of Onset. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Cagliari.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to compare clinicopathological features of familial non-medullary thyroid cancer (FNMTC) and sporadic non-medullary thyroid cancer (sNMTC) and assess whether age at onset contributes to the different behavior of these 2 entities.

Design

A retrospective study including 31 patients with FNMTC, and 31 age- and sex-matched patients with sNMTC.

Methods

Histological variant, multifocality, tumor infiltration, angioinvasion, TNM stage, lymph node metastasis, BRAF and p53 expression, ATA risk stratification, and the presence of chronic lymphocytic thyroiditis (CLT) were compared between groups. Then, we identified a cutoff age to stratify patients by age of onset (≤35 vs >35 years).

Results

FNMTC presented at a more advanced stage at diagnosis compared to sNMTC, with a higher proportion of medium-high TNM stages. Among FNMTC, early-onset (≤35 years) cases showed higher BRAF expression, more frequent lymph node metastases, a higher proportion of medium-high TNM stages, and intermediate-to-high ATA risk compared to late-onset cases (>35 years). Medium-high TNM stage, BRAF expression, and lymph node metastases were observed more frequently in early onset FNMTC than in age-matched sNMTC. Late-onset FNMTC patients exhibited a higher prevalence of CLT than early-onset FNMTC and late-onset sNMTC patients.

Conclusions

These findings underscore the relevance of age at disease onset in shaping the clinical phenotypes of FNMTC. The distinct pathological features of early-onset vs late-onset FNMTC suggest different pathophysiological mechanisms, with the former likely driven by direct genetic/oncogenic alterations, and the latter influenced by autoimmune thyroiditis–related carcinogenesis, a hypothesis that warrants further investigation in larger prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryThyroid NeoplasmsAge of OnsetRetrospective StudiesNeoplasm StagingPhenotypeHumansMaleFemaleAdultNeoplasm InvasivenessLymphatic MetastasisProto-Oncogene Proteins B-rafTumor Suppressor Protein p53Hashimoto DiseaseMiddle Aged

Stichwörter der Autor:innen

autoimmune thyroid diseaseearly onset familial thyroid cancerfamilial thyroid cancersporadic thyroid cancerthyroid cancer

Substanzen

BRAF protein, humanProto-Oncogene Proteins B-rafTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari 09042, Italy.
  • Pathology Unit, San Giovanni di Dio Hospital, Cagliari 09124, Italy.
  • Surgery Unit, Department of Surgical Sciences, University of Cagliari, Cagliari 09042, Italy.
  • Department of Biomedical Sciences, Biochemistry, Biology and Genetics Unit, University of Cagliari, Cagliari 09042, Italy.

ORCID-Profile: Giulia Lanzolla

Förderung

  • University of Cagliari

Zitieren

APA

Mura, C., Corrias, S., Lecca, M., Lai, M. L., Canu, G. L., Medas, F., Mariotti, S., Calò, P. G., Caria, P., Lanzolla, G., & Boi, F. (2026). Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms. European Journal of Endocrinology, 194(4), 510-518. https://doi.org/10.1093/ejendo/lvag059

Vancouver

Mura C, Corrias S, Lecca M, Lai ML, Canu GL, Medas F, et al. Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms. European Journal of Endocrinology. 2026;194(4):510-518. doi:10.1093/ejendo/lvag059

BibTeX
@article{Mura2026,
  author = {Mura, Chiara and Corrias, Silvia and Lecca, Mara and Lai, Maria Letizia and Canu, Gian Luigi and Medas, Fabio and Mariotti, Stefano and Calò, Pietro Giorgio and Caria, Paola and Lanzolla, Giulia and Boi, Francesco},
  title = {Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms},
  journal = {European Journal of Endocrinology},
  year = {2026},
  volume = {194},
  number = {4},
  pages = {510--518},
  doi = {10.1093/ejendo/lvag059}
}
Kostenlos starten →